Prognostic impact of thyroid function in patients with incident heart failure: a nationwide study.

IF 6.7 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiac Failure Pub Date : 2024-12-11 DOI:10.1016/j.cardfail.2024.11.010
Jeppe Kofoed Petersen, Christian Selmer, Søren Lund Kristensen, Rasmus Rørth, Adelina Yafasova, Lucas Grove Bager Vejlstrup, Sam Aiyad Ali, Morten Schou, Lars Køber, Emil Loldrup Fosbøl, Lauge Østergaard
{"title":"Prognostic impact of thyroid function in patients with incident heart failure: a nationwide study.","authors":"Jeppe Kofoed Petersen, Christian Selmer, Søren Lund Kristensen, Rasmus Rørth, Adelina Yafasova, Lucas Grove Bager Vejlstrup, Sam Aiyad Ali, Morten Schou, Lars Køber, Emil Loldrup Fosbøl, Lauge Østergaard","doi":"10.1016/j.cardfail.2024.11.010","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>There is a paucity of data on the prognostic impact of thyroid dysfunction in patients with heart failure (HF). We aimed to examine the association between these two conditions in a nationwide cohort of patients with HF.</p><p><strong>Methods: </strong>This Danish cohort study evaluated the thyroid function of patients diagnosed with first-time HF from 2000-2021. Patients were categorized according to laboratory-based thyroid function values (euthyroid, overt/subclinical hypothyroidism, or hyperthyroidism) recorded within one year before the HF diagnosis. The primary outcome was a composite of mortality and hospitalization for HF, examined using the cumulative incidence function. Cox proportional hazard analysis adjusted for major comorbidities was performed to investigate differences in outcomes among groups.</p><p><strong>Results: </strong>Of the 58,067 individuals included in this study (43.9% female, median age 75.7 years [p25-p75:66.4-83.5]), 54,319 (93.6%) were euthyroid, 1,669 (2.9%) had subclinical hypothyroidism, 239 (0.4%) had overt hypothyroidism, 1,633 (2.8%) had subclinical hyperthyroidism, and 207 (0.4%) had overt hyperthyroidism. Compared with euthyroid patients, the adjusted one-year HR of the composite outcome was 1.11 (95% CI, 1.02-1.20) in patients with subclinical hypothyroidism, 1.24 (95% CI, 1.02-1.51) in patients with overt hypothyroidism, 1.06 (95% CI, 0.98-1.15) in patients with subclinical hyperthyroidism, and 1.27 (95% CI, 1.00-1.60) in patients with overt hyperthyroidism. This positive association was mainly driven by the increased mortality rates.</p><p><strong>Conclusion: </strong>In patients with incident HF, the presence of both hypo- and hyperthyroidism up to one year prior to HF diagnosis was associated with increased risk of the composite of mortality and hospitalization for HF. Our results demonstrate a high-risk group of patients in need of increased clinical awareness.</p>","PeriodicalId":15204,"journal":{"name":"Journal of Cardiac Failure","volume":" ","pages":""},"PeriodicalIF":6.7000,"publicationDate":"2024-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiac Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cardfail.2024.11.010","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: There is a paucity of data on the prognostic impact of thyroid dysfunction in patients with heart failure (HF). We aimed to examine the association between these two conditions in a nationwide cohort of patients with HF.

Methods: This Danish cohort study evaluated the thyroid function of patients diagnosed with first-time HF from 2000-2021. Patients were categorized according to laboratory-based thyroid function values (euthyroid, overt/subclinical hypothyroidism, or hyperthyroidism) recorded within one year before the HF diagnosis. The primary outcome was a composite of mortality and hospitalization for HF, examined using the cumulative incidence function. Cox proportional hazard analysis adjusted for major comorbidities was performed to investigate differences in outcomes among groups.

Results: Of the 58,067 individuals included in this study (43.9% female, median age 75.7 years [p25-p75:66.4-83.5]), 54,319 (93.6%) were euthyroid, 1,669 (2.9%) had subclinical hypothyroidism, 239 (0.4%) had overt hypothyroidism, 1,633 (2.8%) had subclinical hyperthyroidism, and 207 (0.4%) had overt hyperthyroidism. Compared with euthyroid patients, the adjusted one-year HR of the composite outcome was 1.11 (95% CI, 1.02-1.20) in patients with subclinical hypothyroidism, 1.24 (95% CI, 1.02-1.51) in patients with overt hypothyroidism, 1.06 (95% CI, 0.98-1.15) in patients with subclinical hyperthyroidism, and 1.27 (95% CI, 1.00-1.60) in patients with overt hyperthyroidism. This positive association was mainly driven by the increased mortality rates.

Conclusion: In patients with incident HF, the presence of both hypo- and hyperthyroidism up to one year prior to HF diagnosis was associated with increased risk of the composite of mortality and hospitalization for HF. Our results demonstrate a high-risk group of patients in need of increased clinical awareness.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
背景:有关甲状腺功能障碍对心力衰竭(HF)患者预后影响的数据很少。我们的目的是在一个全国性的心力衰竭患者队列中研究这两种疾病之间的关联:这项丹麦队列研究评估了 2000-2021 年间首次被诊断为心力衰竭的患者的甲状腺功能。根据确诊心房颤动前一年内记录的实验室甲状腺功能值(甲状腺功能正常、明显/亚临床甲状腺功能减退或甲状腺功能亢进)对患者进行分类。主要结果是死亡率和心房颤动住院率的综合,采用累积发病率函数进行检验。在对主要合并症进行调整后,进行了 Cox 比例危险分析,以研究各组间结果的差异:本研究共纳入 58067 人(43.9% 为女性,中位年龄为 75.7 岁 [p25-p75:66.4-83.5]),其中 54319 人(93.6%)为甲状腺功能正常,1669 人(2.9%)为亚临床甲状腺功能减退,239 人(0.4%)为明显甲状腺功能减退,1633 人(2.8%)为亚临床甲状腺功能亢进,207 人(0.4%)为明显甲状腺功能亢进。与甲状腺功能正常的患者相比,亚临床甲减患者的综合结果调整后一年HR为1.11(95% CI,1.02-1.20),显性甲减患者的综合结果调整后一年HR为1.24(95% CI,1.02-1.51),亚临床甲亢患者的综合结果调整后一年HR为1.06(95% CI,0.98-1.15),显性甲亢患者的综合结果调整后一年HR为1.27(95% CI,1.00-1.60)。这种正相关性主要是由于死亡率的增加:甲状腺功能减退症和甲状腺功能亢进症患者在确诊心房颤动前一年内同时存在甲状腺功能减退症和甲状腺功能亢进症,与死亡率和心房颤动住院率的综合风险增加有关。我们的研究结果表明,这是一个需要提高临床认识的高危人群。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cardiac Failure
Journal of Cardiac Failure 医学-心血管系统
CiteScore
7.80
自引率
8.30%
发文量
653
审稿时长
21 days
期刊介绍: Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure - pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.
期刊最新文献
At The Heart of Transition: A Journey in Gratitude. Efficacy and Safety of Sodium Zirconium Cyclosilicate in the Management of Hyperkalemia in Patients with Heart Failure with Reduced and Mildly Reduced Ejection Fraction and Chronic Kidney Disease Treated with Spironolactone: rational for and design of the REGISTA-K trial. Facilitators and Barriers to Values Discussions Following LVAD Implantation: Perspectives from Diverse Patients and Family Caregivers. Effectiveness of Virtual Care Team Guided Management of Hospitalized Patients with HFrEF by Ethnicity. Performance of Clinical Scoring Systems in the Diagnosis of Transthyretin Amyloid Cardiomyopathy in a Diverse Patient Cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1